History of cannabis as medicine: Nineteenth century Irish physicians and correlations of their observations to modern research

Cannabis sativa L. - Botany and Biotechnology

Volumn , Issue , 2017, Pages 63-78

  Russo, Ethan B ^a  

^a PHYTECS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019530683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-54564-6_2     Document Type: Chapter

References (77)

1. Akerman S, Holland PR, Goadsby PJ (2007) Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther 320(1):64-71
2. Akerman S, Kaube H, Goadsby PJ (2003) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309 (1):56-63
3. Akerman S, Kaube H, Goadsby PJ (2004) Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142:1354-1360
4. Allen DE, Hatfield G (2004) Medicinal plants in folk tradition: an ethnobotany of britain and ireland. Timber Press, Portland, OR
5. Anonymous (1843) On the Cannabis indica, or indian hemp. Pharm J Trans 2:594-595
6. Anonymous (1870) Retirement of Mr. Donovan, of Dublin. Medical Press and Circular pp 447-448
7. Anonymous (1898) Asylum worthies. Mr. Richard Greene, F.R.C.P. Edin. The Hospital
8. Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431(7006):312-316
9. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404(6773):84-87
10. Besnard P (1816) Observations on the promoting the cultivation of hemp and flax, and extending the linen and hempen manufactures in the south of Ireland. W. Folds and Sons, Cork, Ireland
11. Blake DR, Robson P, Ho M, Jubb RW, McCabe CS (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatol (Oxford) 45(1):50-52
12. Cameron CA (1886) History of the Royal College of Surgeons in Ireland and the Irish Schools of Medicine: Numerous Biographical Sketches: Also a Medical Bibliography. Fannin and Co., Dublin
13. Cassidy LM, Martiniano R, Murphy EM, Teasdale MD, Mallory J, Hartwell B, Bradley DG (2016) Neolithic and Bronze Age migration to Ireland and establishment of the insular Atlantic genome. Proc Natl Acad Sci U S A 113(2):368-373. doi:10.1073/pnas.1518445113
14. Churchill F (1849) Essays on the puerperal fever and other diseases peculiar to women. Selected from the writings of British authors previous to the close of the eighteenth century. Sydenham Society. Sydenham Society, London
15. Coakley D (1988) The irish school of medicine: outstanding practitioners of the 19th century. Town House, Dublin
16. Coakley D (1992) Irish masters of medicine. Town House, Dublin
17. Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, Kennedy K, Schram K (1991) Controlled clinical trial of cannabidiol in Huntington's disease. Pharmacol Biochem Behav 40 (3):701-708
18. Corrigan D (1845a) Cases of chorea and tic-doloureux-treatment by tincture of Indian hemp and electro-magnetism, with observations. Dublin Hospital Gazette 10:143-145
19. Corrigan D (1845b) Treatment of chorea by the use of Cannabis indica. Medical Times 12:291-292
20. Corrigan D (1855) Choree (emploi des inhalation de chloroforme dans le traitement de la).-Emploi du haschish dan la meme maladie. J de Pharm et de Chim 27:312-314
21. Dalnoki O, Jacomet S (2002) Some aspects of Late Iron Age agriculture based on the first results of an archaeobotanical investigation at Corvin ter, Budapest, Hungary. Veg Hist Archaeobotany 11:9-15
22. Dark P (2000) The environment of Britain in the first millennium AD. Duckworth, London
23. Dastur JF (1962) Medicinal plants of India and Pakistan; A concise work describing plants used for drugs and remedies according to Ayurvedic, Unani and Tibbi systems and mentioned in British and American pharmacopoeias. D.B. Taraporevala Sons, Bombay
24. Dodick DW (2006) Clinical practice. Chronic daily headache. N Engl J Med 354(2):158-165
25. Donovan M (1832) A treatise on chemistry. Longman, Rees, Orme, Brown, Green and Longman, London, Cabinet Cyclopedia
26. Donovan M (1844) On the physical and medicinal qualities of Indian hemp (Cannabis indica) with observation on the best mode of administration and cases illustrative of its powers. Hodges and Smith, Dublin
27. Donovan M (1845) On the physical and medicinal qualities of Indian hemp (Cannabis indica); With observations on the best mode of administration, and cases illustrative of its powers. Dublin J Med Sci 26(368-402):459-461
28. Donovan M (1851) Observations on the resin of Indian hemp. Dublin Med Press 25(637):182-183
29. Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 15(6):510-521
30. Fernandez-Ruiz J, Moreno-Martet M, Rodriguez-Cueto C, Palomo-Garo C, Gomez-Canas M, Valdeolivas S, Guaza C, Romero J, Guzman M, Mechoulam R, Ramos JA (2011) Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 163(7):1365-1378. doi:10. 1111/j.1476-5381.2011.01365.x
31. Fride E, Sanudo-Pena MC (2002) Cannabinoids and endocannabinoids: behavioral and developmental aspects. In: Onaivi ES (ed) Biology of marijuana. From gene to hehavior. Taylor and Francis, London, pp 174-204
32. Friedman D, Devinsky O (2015) Cannabinoids in the treatment of epilepsy. N Engl J Med 373 (11):1048-1058. doi:10.1056/NEJMra1407304
33. Glass M, Dragunow M, Faull RL (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77(2):299-318
34. Gorman M (1983) Sir William B. O'Shaughnessy, pioneer chemical educator in India. Ambix 30 (Part 2):107-116
35. Gorman M (1984) Sir William Brooke O'Shaughnessy, F.R.S. (1809-1889), Anglo-Indian forensic chemist. Notes and Records of the Roayl Society of London 39 (1):51-64
36. Gottschling S (2011) Cannbinoide bei Kindern. Gute Erfahrungen bei Schmerzen, Spastik und in der Onkologie. Angew Schmerztherapie und Palliativmedizin 1:55-57
37. Grattan JHG, Singer CJ (1952) Anglo-Saxon magic and medicine. Illustrated specially from the semi-pagan text "Lacnunga,". Publications of the Wellcome Historical Medical Museum. New ser., no. 3. Oxford University Press, London, New York
38. Greene JJ (1899) Celtic royal genealogy. http://wc.rootsweb.ancestry.com/cgi-bin/igm.cgi?op= GET&db=aet-t&id=I61019#s1
39. Greene R (1872) Cannabis indica in the treatment of migraine. Practitioner 41:267-270
40. Greene R (1874) Epilepsy and migraine: a clinical note. J Ment Sci 20:96-97
41. Greene R (1888) The treatment of migraine with Indian hemp. Practitioner 41:35-38
42. Izzo AA, Capasso F, Costagliola A, Bisogno T, Marsicano G, Ligresti A, Matias I, Capasso R, Pinto L, Borrelli F, Cecio A, Lutz B, Mascolo N, Di Marzo V (2003) An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 125(3):765-774
43. Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126(1):21-38. doi:10.1016/j.pharmthera.2009.12.005 (S0163-7258 (10)00006-9 [pii])
44. King A (2015) Medical marvel: the uses of cannabis continue to grow. Irish scientists are exploring the chemicals found in cannabis to develop drugs to treat pain, anxiety, MS and Alzheimer's. Irish Times, Apr 16
45. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97(17):9561-9566
46. Mikuriya TH (1973) Marijuana: Medical papers, 1839-1872. Medi-comp Press, Oakland, CA
47. Mikuriya TH (2004) Cannabis as a substitute for alcohol: a harm-reduction approach. Journal of Cannabis Therapeutics 4(1):79-93
48. Mills JH (2003) Cannabis Britannica: empire, trade, and prohibition 1800-1928. Oxford University Press, Oxford
49. Moloney MF (1919) Irish Ethno-Botany and the evolution of medicine in Ireland. M. H. Gill and Son, Dublin
50. Notcutt W, Langford R, Davies P, Ratcliffe S, Potts R (2012) A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols). Mult Scler 18(2):219-228. doi:10.1177/ 1352458511419700
51. Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P (2011) A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex((R))), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 18(9):1122-1131. doi: 10.1111/ j.1468-1331.2010.03328.x
52. Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 133(1-3):210-220
53. O'Shaughnessy WB (1838-1840) On the preparations of the Indian hemp, or gunjah (Cannabis indica); their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Transactions of the medical and physical society of Bengal:71-102, 421-461
54. O'Shaughnessy WB (1839) On the preparation of the Indian hemp, or Gunjah. J Asiatic Soc Bengal 8
55. O'Shaughnessy WB (1842) Bengal dispensatory and companion to the phamacopoeia. Allen, London
56. O'Shaughnessy WB (1843a) Indian hemp. Provincial Med J Retrospect Med Sci 5:397-398
57. O'Shaughnessy WB (1843b) On the preparations of the Indian hemp, or gunjah (Cannabis indica). Their effects on the animal system in health, and their utility in the treatment of tetanus and other convulsive diseases. Provincial Med J Retrospect Med Sci 5(122, 123):343-347, 363369, 397-398
58. Pertwee RG (1972) The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br J Pharmacol 46(4):753-763
59. Pertwee RG (2001) Cannabinoids and the gastrointestinal tract. Gut 48(6):859-867
60. Porter BE, Jacobson C (2013) Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy and behavior: E&B 29(3):574-577. doi:10. 1016/j.yebeh.2013.08.037
61. Robson P (2005) Abrupt interruption of long-term treatment with Sativex was not associated with a consistent withdrawal syndrome or serious withdrawal symptoms in a sample of patients with multiple sclerosis. Multiple Sclerosis (submitted)
62. Rog DJ, Nurmiko T, Friede T, Young C (2005) Randomized controlled trial of cannabis based medicine in central neuropathic pain due to multiple sclerosis. Neurology 65(6):812-819
63. Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O (2015) Cannabinoids and Epilepsy. Neurotherapeutics 12(4):747-768. doi:10.1007/s13311-015-0375-5
64. Rowland LP (ed) (2000) Merritt's neurology, 10th edn. Lippincott, Williams and Wilkins, Philadelphia
65. Russo E (2002) Cannabis treatments in obstetrics and gynecology: A historical review. J Cannabis Ther 2(3-4):5-35
66. Russo EB (2001) Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment. J Cannabis Ther 1(2):21-92
67. Russo EB (2004) Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuroendocrinol Lett 25(1-2):31-39
68. Russo EB (2005) Cannabis in India: Ancient lore and modern medicine. In: Mechoulam R (ed) Cannabinoids as therapeutics. Birkhauser Verlag, Basel, Switzerland, pp 1-22
69. Russo EB (2011) Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 163(7):1344-1364. doi:10.1111/j.1476-5381.2011.01238.x
70. Russo EB (2014) The pharmacological history of Cannabis. In: Pertwee R (ed) Handbook of cannabinoids. Oxford University Press, Oxford, United Kingdom
71. Russo EB (2016a) Cannabis and epilepsy: an ancient treatment returns to the fore. Epilepsy & behavior: E&B. doi:10.1016/j.yebeh.2016.09.040
72. Russo EB (2016b) Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis Cannabinoid Res 1:154-165. doi:10.1089/can.2016.0009
73. Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729-1743. doi:10. 1002/cbdv.200790150
74. Russo EB, Hohmann AG (2013) Role of cannabinoids in pain management. In: Deer T, Gordin V (eds) Comprehensive treatment of chronic pain by medical, interventional and behavioral approaches. Springer, New York, pp 181-197. doi:10.1007/978-1-4614-1560-2_18
75. Russo EB, Mead AP, Sulak D (2015) Current status and future of cannabis research. Clin Researcher (Apr):58-63
76. Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML, Calabresi P (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure. Neuropsychopharmacology 32(6):1384-1390. doi:10.1038/sj.npp.1301246 (1301246 [pii])
77. Wilde WR (1840) Narrative of a voyage to Madeira, Teneriffe, and along the shores of the Mediterranean, including a visit to Algiers, Egypt, Palestine, Tyre, Rhodes, Telmessus, Cyprus, and Greece. with observations on the present state and prospects of Egypt and Palestine, and on the climate, natural hisory, antiquities, etc. of the countries visited. William Curry, Jun. and Co., Dublin